Tests of a Compton imaging prototype in a monoenergetic 4.44 MeV photon field—a benchmark setup for prompt gamma-ray imaging devices


Tests of a Compton imaging prototype in a monoenergetic 4.44 MeV photon field—a benchmark setup for prompt gamma-ray imaging devices

Golnik, C.; Bemmerer, D.; Enghardt, W.; Fiedler, F.; Hueso-González, F.; Pausch, G.; Römer, K.; Rohling, H.; Schöne, S.; Wagner, L.; Kormoll, T.

Abstract

The finite range of a proton beam in tissue opens new vistas for the delivery of a highly conformal dose distribution in radiotherapy. However, the actual particle range, and therefore the accurate dose deposition, is sensitive to the tissue composition in the proton path. Range uncertainties, resulting from limited knowledge of this tissue composition or positioning errors, are accounted for in the form of safety margins. Thus, the unverified particle range constrains the principle benefit of proton therapy. Detecting prompt gamma-rays, a side product of proton-tissue interaction, aims at an on-line and non-invasive monitoring of the particle range, and therefore towards exploiting the potential of proton therapy. Compton imaging of the spatial prompt gamma-ray emission is a promising measurement approach. Prompt gamma-rays exhibit emission energies of several MeV. Hence, common radioactive sources cannot provide the energy range a prompt gamma-ray imaging device must be designed for. In this work a benchmark measurement-setup for the production of a localized, monoenergetic 4.44MeV gamma-ray source is introduced. At the Tandetron accelerator at the HZDR, the proton-capture resonance reaction 15N(p , alpha gamma4.439)12C is utilized. This reaction provides the same nuclear de-excitation (and gamma-ray emission) occurrent as an intense prompt gamma-ray line in proton therapy. The emission yield is quantitatively described. A two-stage Compton imaging device, dedicated for prompt gamma-ray imaging, is tested at the setup exemplarily. Besides successful imaging tests, the detection efficiency of the prototype at 4.44MeV is derived from the measured data. Combining this efficiency with the emission yield for prompt gamma-rays, the number of valid Compton events, induced by gamma-rays in the energy region around 4.44MeV, is estimated for the prototype being implemented in a therapeutic treatment scenario. As a consequence, the detection efficiency turns out to be a key parameter for prompt gamma-ray Compton imaging limiting the applicability of the prototype in its current realization.

Keywords: Comptonimaging; Dosimetryconceptsandapparatus; Imagereconstructioninmedicalimaging; Instrumentation for hadron therapy

Beteiligte Forschungsanlagen

Verknüpfte Publikationen

Downloads

Permalink: https://www.hzdr.de/publications/Publ-24007